MA46100A - Composition pharmaceutique comprenant de la rosuvastatine et de l'ézétimibe et son procédé de préparation - Google Patents
Composition pharmaceutique comprenant de la rosuvastatine et de l'ézétimibe et son procédé de préparationInfo
- Publication number
- MA46100A MA46100A MA046100A MA46100A MA46100A MA 46100 A MA46100 A MA 46100A MA 046100 A MA046100 A MA 046100A MA 46100 A MA46100 A MA 46100A MA 46100 A MA46100 A MA 46100A
- Authority
- MA
- Morocco
- Prior art keywords
- ezetimibe
- rosuvastatin
- preparation
- pharmaceutical composition
- composition consisting
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229940074795 rosuvastatin and ezetimibe Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ2016-539A CZ2016539A3 (cs) | 2016-09-05 | 2016-09-05 | Farmaceutická kompozice obsahující dvě rozdílné účinné látky a způsob její přípravy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA46100A true MA46100A (fr) | 2019-07-10 |
Family
ID=59955311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA046100A MA46100A (fr) | 2016-09-05 | 2017-08-31 | Composition pharmaceutique comprenant de la rosuvastatine et de l'ézétimibe et son procédé de préparation |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11786526B2 (fr) |
| EP (1) | EP3506888A1 (fr) |
| JP (1) | JP7094944B2 (fr) |
| KR (1) | KR102517765B1 (fr) |
| CN (1) | CN110418637A (fr) |
| CZ (1) | CZ2016539A3 (fr) |
| EA (1) | EA201990652A1 (fr) |
| IL (1) | IL265172B (fr) |
| MA (1) | MA46100A (fr) |
| MX (1) | MX389761B (fr) |
| TW (1) | TWI811195B (fr) |
| WO (1) | WO2018041282A1 (fr) |
| ZA (1) | ZA201901342B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7115825B2 (ja) * | 2017-06-28 | 2022-08-09 | 日医工株式会社 | エゼチミブ含有経口製剤及びその製造方法 |
| JP2019014700A (ja) * | 2017-07-11 | 2019-01-31 | 大原薬品工業株式会社 | エゼチミブ含有口腔内崩壊錠及びその製造方法 |
| WO2021019499A1 (fr) | 2019-07-31 | 2021-02-04 | TECNIMEDE - Sociedade Técnico-medicinal, SA | Compositions solides orales à libération immédiate à unités multiples, procédés et utilisations de celles-ci |
| WO2022023206A1 (fr) * | 2020-07-27 | 2022-02-03 | Krka, D.D., Novo Mesto | Comprimé bicouche comprenant de l'ézétimibe et de l'atorvastatine |
| JP2022104836A (ja) * | 2020-12-29 | 2022-07-11 | 日本ジェネリック株式会社 | エゼチミブ及びロスバスタチンを含む錠剤 |
| CN120000605A (zh) * | 2025-04-21 | 2025-05-16 | 山东齐都药业有限公司 | 瑞舒伐他汀依折麦布制剂及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE390127T1 (de) * | 2003-09-01 | 2008-04-15 | Jpm The Jordanian Pharmaceutic | Universelle zusammensetzung zur kontrollierten wirkstoffabgabe enthaltend chitosan |
| WO2009024889A2 (fr) | 2007-08-21 | 2009-02-26 | Ranbaxy Laboratories Limited | Composition pharmaceutique comprenant un inhibiteur de réductase hmg-coa et un ézétimibe |
| EP2168573A1 (fr) | 2008-09-30 | 2010-03-31 | LEK Pharmaceuticals D.D. | Formulations contentant d'ézétimibe |
| EP2448919A2 (fr) | 2009-07-02 | 2012-05-09 | Mahmut Bilgic | Formulation pharmaceutique permettant d'augmenter la solubilité et la stabilité |
| US8927021B2 (en) * | 2009-07-28 | 2015-01-06 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszventarsasag | Granulating process and thus prepared granulate |
| TR201009397A2 (tr) * | 2010-11-11 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Rosuvastatin içeren farmasötik bileşimler. |
| WO2013066279A1 (fr) | 2011-10-13 | 2013-05-10 | Mahmut Bilgic | Formes pharmaceutiques solides contenant de l'ézétimibe |
| EP2844233B1 (fr) * | 2012-05-01 | 2020-05-06 | Althera Life Sciences, LLC | Formulation de comprimé oral constituée d'une combinaison fixe de rosuvastatine et d'ézétimibe pour le traitement de l'hyperlipidémie et de maladies cardiovasculaires |
| MX2012014970A (es) | 2012-12-18 | 2013-08-27 | Hetlabs Mexico S A De C V | Composiciones farmaceuticas que comprenden ezetimiba y rosuvastatina de calcio amorfo novedoso. |
| HU231036B1 (hu) * | 2013-09-30 | 2019-12-30 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Koleszterin bioszintézis gátló hatóanyagot és koleszterin abszorpciót gátló hatóanyagot tartalmazó kombinációs gyógyszerkészítmény |
| CN103585157B (zh) | 2013-11-13 | 2016-02-03 | 武汉武药科技有限公司 | 一种含依折麦布和瑞舒伐他汀的双层片及其制备方法 |
| KR20150079373A (ko) | 2013-12-30 | 2015-07-08 | 한미약품 주식회사 | 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 |
| KR101977785B1 (ko) * | 2014-06-25 | 2019-05-14 | 한미약품 주식회사 | 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제 및 그 제조방법 |
| FR3030251B1 (fr) * | 2014-12-22 | 2018-11-02 | L'oreal | Composition comprenant un compose 4-(heterocycloalkyl)-benzene-1,3-diol et un solvant particulier |
| CN105310993A (zh) | 2015-11-17 | 2016-02-10 | 深圳信立泰药业股份有限公司 | 一种含有依折麦布的药物组合物及其制备方法 |
-
2016
- 2016-09-05 CZ CZ2016-539A patent/CZ2016539A3/cs unknown
-
2017
- 2017-08-31 MA MA046100A patent/MA46100A/fr unknown
- 2017-08-31 JP JP2019512660A patent/JP7094944B2/ja active Active
- 2017-08-31 EP EP17771980.4A patent/EP3506888A1/fr active Pending
- 2017-08-31 MX MX2019002516A patent/MX389761B/es unknown
- 2017-08-31 TW TW106129702A patent/TWI811195B/zh active
- 2017-08-31 CN CN201780067887.8A patent/CN110418637A/zh active Pending
- 2017-08-31 IL IL265172A patent/IL265172B/en unknown
- 2017-08-31 WO PCT/CZ2017/050037 patent/WO2018041282A1/fr not_active Ceased
- 2017-08-31 EA EA201990652A patent/EA201990652A1/ru unknown
- 2017-08-31 US US16/330,268 patent/US11786526B2/en active Active
- 2017-08-31 KR KR1020197009428A patent/KR102517765B1/ko active Active
-
2019
- 2019-03-04 ZA ZA2019/01342A patent/ZA201901342B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP7094944B2 (ja) | 2022-07-04 |
| KR20190045286A (ko) | 2019-05-02 |
| JP2019526591A (ja) | 2019-09-19 |
| CN110418637A (zh) | 2019-11-05 |
| US11786526B2 (en) | 2023-10-17 |
| BR112019004269A2 (pt) | 2019-06-04 |
| EP3506888A1 (fr) | 2019-07-10 |
| ZA201901342B (en) | 2020-10-28 |
| US20200009136A1 (en) | 2020-01-09 |
| KR102517765B1 (ko) | 2023-04-03 |
| TWI811195B (zh) | 2023-08-11 |
| MX389761B (es) | 2025-03-20 |
| MX2019002516A (es) | 2019-06-17 |
| IL265172A (en) | 2019-05-30 |
| IL265172B (en) | 2022-09-01 |
| CZ2016539A3 (cs) | 2018-03-14 |
| EA201990652A1 (ru) | 2019-08-30 |
| WO2018041282A1 (fr) | 2018-03-08 |
| TW201818938A (zh) | 2018-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3437637A4 (fr) | Préparation pharmaceutique de palbociclib et son procédé de préparation | |
| EP3449956A4 (fr) | Composition d'hydrogel médical, hydrogel médical, leur procédé de préparation et leur application | |
| EP3486242A4 (fr) | Dérivé d'oxopicolinamide, son procédé de préparation et son utilisation pharmaceutique | |
| EP3353841A4 (fr) | Procédé de préparation et d'application de composites de carbone-sélénium | |
| EP3447137A4 (fr) | Préparation d'enzyme liquide et son procédé de préparation | |
| EP3357491A4 (fr) | Composition pharmaceutique contenant un médicament anionique, et son procédé de préparation | |
| EP3524603A4 (fr) | Inhibiteur de fgfr4, son procédé de préparation et son utilisation pharmaceutique | |
| EP3495362A4 (fr) | Dérivé de l'acide thioglycolique imidazopyridine, son procédé de préparation et son application | |
| EP3653202A4 (fr) | Préparation pharmaceutique et son procédé de préparation | |
| EP3393647A4 (fr) | Procédé d'encapsulation de composés biologiques, thérapeutiques et d'agents d'imagerie solubles | |
| EP3305292A4 (fr) | Composition pharmaceutique d'inhibiteur de mek et procédé de préparation de celle-ci | |
| EP3349762A4 (fr) | Co-cristaux d'inhibiteurs de sglt2, procédé pour leur préparation et compositions pharmaceutiques de ceux-ci | |
| EP3824897A4 (fr) | Composition de médicine traditionnelle chinoise et son procédé de préparation et d'application | |
| EP3744316A4 (fr) | Composition pharmaceutique ophtalmique, son procédé de préparation et son application | |
| EP3730491A4 (fr) | Dérivé d'isoxazole, son procédé de préparation et son utilisation | |
| EP3404024A4 (fr) | Dérivé de quinazolinone, son procédé de préparation, composition pharmaceutique, et applications associées | |
| EP3398615A4 (fr) | Composition pharmaceutique mucoadhésive et son procédé de préparation | |
| EP3733650A4 (fr) | Procédé de préparation d'un intermédiaire d'élagolix et composition associée | |
| EP3731833A4 (fr) | Compositions contenant de la thymohydroquinone et leur procédé de préparation | |
| EP3527195A4 (fr) | Préparation pharmaceutique contenant du polyéthylène gylcol loxenatide et son procédé de préparation | |
| EP3632906A4 (fr) | Dérivé d'azaaryle, son procédé de préparation et son application pour une utilisation en pharmacie | |
| EP3438105A4 (fr) | Composé de diaryl-b-lactame et son procédé de préparation et utilisation pharmaceutique associée | |
| EP3593785A4 (fr) | Composition dentaire et son procédé de préparation | |
| EP3733164A4 (fr) | Microparticules comprenant de la moxidectine et leur procédé de préparation | |
| EP3413882A4 (fr) | Méthode et composition pharmaceutique pour le traitement de la neurodégénérescence |